Our strategy

Read about our £1.3bn programme to accelerate scientific innovation and solve some of the most complex healthcare challenges.

Our aim is to accelerate the progression of affordable and accessible solutions to tackle infectious diseases around the world.

We’re investing up to £100m to tackle neurodegenerative conditions.

Find out how we’re accelerating scientific innovation for people living with bronchiectasis and cystic fibrosis and protecting people from COVID-19.

We’re investing over £100m to accelerate rare disease treatments and diagnostics